The mission of these centers will be to specifically target the significant endemic diseases within those countries, providing the training and expertise to allow local production and distribution of pharmaceuticals effective in treatment regimes. S eldom, if ever, has science or scientists provided us risk-free solutions to problems. Benefits of new technologies are not always apparent or equally distributed. What may help a farmer reduce his input cost or minimize damage to the environment, may not directly benefit the consumer or those that process, manufacture or distribute the goods produced. Introduction of new scientific methods, processes and the products created or modified by them, require proper government oversight to ensure that any product eventually released, for use by the consuming public, will be judged safe.
Risk assessment is an integral part of the decision making process.
This risk assessment should be done against a background of understanding and consent of the public it is intended to serve. People within the Developing World are entitled to be informed and educated about the risks and benefits of the new scientific methods. Novatero will assist in protecting an involved public's right to know. N ovaTero has established a broad-based board of directors to help develop and implement specific plans of action. The board eventually will include individuals from several developing nations.